IMMray®PanCan-d

IMMray® PanCan-d is a blood test for the early detection of pancreatic cancer, for use in individuals at risk for developing familial or hereditary pancreatic ductal adenocarcinoma (PDAC).

In a recent study (Brand RE et al Clin Translat Gastroenterol 2022), IMMray PanCan-d was able to detect early stage PDAC (stage I & II) with 89% sensitivity and all stage PDAC with 92% sensitivity, with 99% specificity for both early and all stage PDAC.

Immunovia, Inc.

immunoviainc.com

Cindy Callahan, RN

cindy.callahan@immunovia.com

(508) 613-8186

Connect With Us on Social Media